Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 May;28(2):226–232.

Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.

P Davis, R H Cumming, J Verrier-Jones
PMCID: PMC1540750  PMID: 301447

Abstract

Eighty-nine sera from nineteen patients with systemic lupus erythematosus (SLE) have been studied to determine the relationship between levels of DNA-binding activity, complement consumption and evidence of circulating immune complexes. There was a good correlation between the height of DNA binding, a rising C3i and a reciprocal fall in C3, C4 and CH50 levels. These latter measurements provided useful supplemental information when studied serially. There was a good correlation between the results of the various methods used for the detection of circulating immune complexes, and these were found in almost half the sera with DNA binding over 70%. It is concluded that serial studied of DNA binding, complement levels, and direct tests for immune complexes, may provide valuable information in the management of patients with SLE.

Full text

PDF
226

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V., Winchester R. J., Kunkel H. G. Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion. Immunology. 1970 Dec;19(6):909–919. [PMC free article] [PubMed] [Google Scholar]
  2. Alper C. A., Rosen F. S. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients. J Clin Invest. 1967 Dec;46(12):2021–2034. doi: 10.1172/JCI105691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carr R. I., Harbeck R. J., Hoffman A. A., Pirofsky B., Bardana E. J. Clinical studies on the significance of DNA:anti-DNA complexes in the systemic circulation and cerebrospinal fluid (CSF) of patients with systemic lupus erythematosus. J Rheumatol. 1975 Jun;2(2):184–193. [PubMed] [Google Scholar]
  4. Cream J. J. Anticomplementary sera in cutaneous vasculitis. Br J Dermatol. 1973 Dec;89(6):555–559. doi: 10.1111/j.1365-2133.1973.tb07579.x. [DOI] [PubMed] [Google Scholar]
  5. Heusser C., Boesman M., Nordin J. H., Isliker H. Effect of chemical and enzymatic radioiodination on in vitro human Clq activities. J Immunol. 1973 Mar;110(3):820–828. [PubMed] [Google Scholar]
  6. Hughes G. R., Cohen S. A., Christian C. L. Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. Ann Rheum Dis. 1971 May;30(3):259–264. doi: 10.1136/ard.30.3.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jones J. V., Cumming R. H., Bucknall R. C., Asplin C. M. Plasmapheresis in the management of acute systemic lupus erythematosus? Lancet. 1976 Apr 3;1(7962):709–711. doi: 10.1016/s0140-6736(76)93088-9. [DOI] [PubMed] [Google Scholar]
  8. Koffler D., Kunkel H. G. Mechanisms of renal injury in systemic lupus erythematosus. Am J Med. 1968 Aug;45(2):165–169. doi: 10.1016/0002-9343(68)90034-x. [DOI] [PubMed] [Google Scholar]
  9. Lightfoot R. W., Redecha P. B., Levesanos N. Longitudinal studies of anti-DNA antibody levels in SLE. Scand J Rheumatol Suppl. 1975;11:52–58. doi: 10.3109/03009747509095629. [DOI] [PubMed] [Google Scholar]
  10. McGhee J. D., von Hippel P. H. Formaldehyde as a probe of DNA structure. I. Reaction with exocyclic amino groups of DNA bases. Biochemistry. 1975 Mar 25;14(6):1281–1296. doi: 10.1021/bi00677a029. [DOI] [PubMed] [Google Scholar]
  11. Morgan A. R., Pulleyblank D. E. Native and denatured DNA, cross-linked and palindromic DNA and circular covalently-closed DNA analysed by a sensitive fluorometric procedure. Biochem Biophys Res Commun. 1974 Nov 27;61(2):396–403. doi: 10.1016/0006-291x(74)90970-x. [DOI] [PubMed] [Google Scholar]
  12. Penttinen K., Vaheri A., Myllylä G. Detection and characterization of immune complexes by the platelet aggregation test. I. Complexes formed in vitro. Clin Exp Immunol. 1971 Mar;8(3):389–397. [PMC free article] [PubMed] [Google Scholar]
  13. Pincus T., Schur P. H., Rose J. A., Decker J. L., Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med. 1969 Sep 25;281(13):701–705. doi: 10.1056/NEJM196909252811304. [DOI] [PubMed] [Google Scholar]
  14. Svec K. H., Allen S. T. Antibody to nuclear material eluted from isolated spleen vessels in systemic lupus erythematosus. Science. 1970 Oct 30;170(3957):550–551. doi: 10.1126/science.170.3957.550. [DOI] [PubMed] [Google Scholar]
  15. Versey J. M., Hobbs J. R., Holt P. J. Complement metabolism in rheumatoid arthritis. I. Longitudinal studies. Ann Rheum Dis. 1973 Nov;32(6):557–564. doi: 10.1136/ard.32.6.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wold R. T., Young F. E., Tan E. M., Farr R. S. Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid. Science. 1968 Aug 23;161(3843):806–807. doi: 10.1126/science.161.3843.806. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES